BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19822571)

  • 21. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.
    Zhang Y; Sanjose SD; Bracci PM; Morton LM; Wang R; Brennan P; Hartge P; Boffetta P; Becker N; Maynadie M; Foretova L; Cocco P; Staines A; Holford T; Holly EA; Nieters A; Benavente Y; Bernstein L; Zahm SH; Zheng T
    Am J Epidemiol; 2008 Jun; 167(11):1321-31. PubMed ID: 18408225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption.
    Kim SH; Kim SH; Yoon HJ; Shin DH; Park SS; Kim YS; Park JS; Jee YK
    Eur J Clin Pharmacol; 2011 Feb; 67(2):121-7. PubMed ID: 20941486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
    Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
    Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma.
    Kilfoy BA; Zheng T; Lan Q; Han X; Qin Q; Rothman N; Holford T; Zhang Y
    Am J Hematol; 2009 May; 84(5):279-82. PubMed ID: 19338043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
    Khedhaier A; Hassen E; Bouaouina N; Gabbouj S; Ahmed SB; Chouchane L
    BMC Cancer; 2008 Apr; 8():109. PubMed ID: 18423013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
    Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors.
    Malik MA; Upadhyay R; Mittal RD; Zargar SA; Mittal B
    Nutr Cancer; 2010; 62(6):734-42. PubMed ID: 20661821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
    Perwitasari DA; Darmawan E; Mulyani UA; Vlies PV; Alffenaar JC; Atthobar J; Wilffert B
    Int J Mycobacteriol; 2018; 7(4):380-386. PubMed ID: 30531039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms.
    Espinoza F; Silverman D; Kogevinas M; Creus A; Fernández F; García-Closas M; Tardon A; García-Closas R; Serra C; Carrato A; Rothman N; Dosemeci M; Malats N; Marcos R
    Cancer Lett; 2008 May; 263(2):259-66. PubMed ID: 18262724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
    Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [POLYMORPHISM OF GLUTHATIONE-S-TRANSFERASE P1 IN CHILDREN WITH REFLUX-ESOPHAGITIS].
    Zagorskiy SE; Melnov SB; Sinevich EA
    Lik Sprava; 2015; (1-2):134-5. PubMed ID: 26118046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between genetic polymorphisms and ovarian cancer risk.
    Delort L; Chalabi N; Satih S; Rabiau N; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
    Anticancer Res; 2008; 28(5B):3079-81. PubMed ID: 19031960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.
    Bin Q; Luo J
    Leuk Lymphoma; 2013 Jan; 54(1):14-20. PubMed ID: 22734843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia.
    Canalle R; Burim RV; Tone LG; Takahashi CS
    Environ Mol Mutagen; 2004; 43(2):100-9. PubMed ID: 14991750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.